
Investments
18Portfolio Exits
8Partners & Customers
10Service Providers
2About Cardinal Health
Cardinal Health improves the cost-effectiveness of healthcare. As the business behind healthcare, Cardinal Health helps pharmacies, hospitals, and ambulatory care sites focus on patient care while reducing costs, improving efficiency and quality, and increasing profitability. Cardinal Health is a link in the healthcare supply chain, providing products from suppliers to medical professionals and healthcare facilities. The company was founded in 1979 and is based in Dublin, Ohio.

Want to inform investors similar to Cardinal Health about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Expert Collections containing Cardinal Health
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find Cardinal Health in 2 Expert Collections, including Fortune 500 Investor list.
Fortune 500 Investor list
590 items
This is a collection of investors named in the 2019 Fortune 500 list of companies. All CB Insights profiles for active investment arms of a Fortune 500 company are included.
Pharma Supply Chain
19 items
Research containing Cardinal Health
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Cardinal Health in 4 CB Insights research briefs, most recently on Nov 16, 2021.

Jan 19, 2021
27 Corporate Innovation Labs In Healthcare
Jan 8, 2021
Cold Chain Captures Executive Attention In Q4’20Latest Cardinal Health News
Mar 21, 2023
" - https://www.reportlinker.com/p06433431/?utm_source=GNW , Boston Scientific Corp, Getinge AB, Coloplast Corp, Cardinal Health, Conavi Medical, Infraredx Inc., BD, MAQUET Holding BV & Co KG, Vitality Medical, BBraun, Koninklijke Philips NV, Lumend Corporation, COVIDien Ag, Acist Medical Systems, Biotronic SE & COKG, Biosense Webster Inc., Cordis, QX Medical and Teleflex Corporated. The global intravascular catheters market grew from $5.9 billion in 2022 to $6.66 billion in 2023 at a compound annual growth rate (CAGR) of 12.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The intravascular catheters market is expected to grow to $10.32 billion in 2027 at a CAGR of 11.6%. The intravascular catheters market consists of sales of pulmonary artery catheters and pacing wires.Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The intravascular catheter is a device typically comprised of a hollow fibre through which blood flows and an immunoisolating membrane separates the transplanted cells from the blood. The intravascular catheters are used for the administration of fluids, medication, blood products, and nutrition, which typically goes into a large vein in the arm or chest. North America was the largest region in the intravascular catheters market in 2022.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravascular catheters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The main intravascular catheter products include short PIVC and integrated/closed PIVC.Short peripheral intravenous catheters (PIVC) are less than or equal to 3 inches in length and are used for intravenous medication and are predominantly inserted in general wards. The different intravascular catheter applications include oncology, gastroenterology, renal disease, infectious diseases and other applications which are used by end-users including hospitals, clinics, ambulatory surgical center and homecare. The rising hospitalization rate owing to the high prevalence of chronic diseases is driving the growth of the intravascular catheters market.Globally, the prevalence of chronic illnesses and ailments is rising. Intravascular catheters are used for taking samples for tests and fluids, nutrients, and blood intake during the treatment of chronic diseases. According to an estimation by a German healthcare company, Fresenius Medical Care, the number of people suffering from chronic kidney failure is expected to increase from 3.7 million patients in 2020 to 4.9 million by 2025. Therefore, the rising hospitalization rate owing to the high prevalence of chronic diseases is expected to propel the growth of the intravascular catheters market over the coming years. The product innovations are a key trend gaining popularity in the intravascular catheters market.Major players in the intravascular catheters market are focusing on innovation of new products with advanced features to strengthen their position. For instance, in July 2022, B. Braun Medical Inc., a German-based medical and pharmaceutical device manufacturing company, introduced Introcan Safety 2 IV Catheter with one-time blood control making IV access safer for the clinician by lowering the danger of blood exposure and needle stick accidents. Furthermore, in March 2022, Shockwave Medical Inc., a firm that creates and sells medical devices, introduced the Shockwave M5+ catheter is particularly made to treat calcified lesions in the iliac, femoral, iliofemoral, popliteal, infra-popliteal, and renal arteries in the lower limbs that are otherwise difficult to treat. In January 2021, Prunus Technology Co., Ltd., a Shenzhen-based developer and manufacturer of various medical equipment, acquired Biosensors International Group, Ltd for an undisclosed amount. Through this acquisition, Prunus Technology expanded into central venous catheters, pressure transducers, pulmonary artery catheters, pacing catheters, thrombolysis catheters, urinary catheters and other medical consumables. Biosensors International Group, Ltd is a Singapore-based company specializing in the critical care consumables business. The countries covered in the intravascular catheters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The intravascular catheters market research report is one of a series of new reports that provides intravascular catheters market statistics, including intravascular catheters industry global market size, regional shares, competitors with an intravascular catheters market share, detailed intravascular catheters market segments, market trends and opportunities, and any further data you may need to thrive in the intravascular catheters industry. This intravascular catheters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
Cardinal Health Investments
18 Investments
Cardinal Health has made 18 investments. Their latest investment was in Ember LifeSciences as part of their Corporate Minority on August 8, 2022.

Cardinal Health Investments Activity

Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
8/10/2022 | Corporate Minority | Ember LifeSciences | Yes | 2 | ||
7/26/2022 | Series A | RxLive | $5M | Yes | 2 | |
4/6/2022 | Corporate Minority | Innara Health | Yes | 1 | ||
1/10/2022 | Series D | |||||
2/6/2020 | Series C |
Date | 8/10/2022 | 7/26/2022 | 4/6/2022 | 1/10/2022 | 2/6/2020 |
---|---|---|---|---|---|
Round | Corporate Minority | Series A | Corporate Minority | Series D | Series C |
Company | Ember LifeSciences | RxLive | Innara Health | ||
Amount | $5M | ||||
New? | Yes | Yes | Yes | ||
Co-Investors | |||||
Sources | 2 | 2 | 1 |
Cardinal Health Portfolio Exits
8 Portfolio Exits
Cardinal Health has 8 portfolio exits. Their latest portfolio exit was Cardinal Health - Cordis Business on March 12, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
3/12/2021 | Divestiture | Cardinal Health - Cordis Business | 2 | ||
Date | 3/12/2021 | ||||
---|---|---|---|---|---|
Exit | Divestiture | ||||
Companies | Cardinal Health - Cordis Business | ||||
Valuation | |||||
Acquirer | |||||
Sources | 2 |
Cardinal Health Acquisitions
32 Acquisitions
Cardinal Health acquired 32 companies. Their latest acquisition was Bendcare on July 06, 2022.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
---|---|---|---|---|---|---|
7/6/2022 | Acquired | 2 | ||||
4/24/2019 | Acquired | 1 | ||||
1/8/2019 | Acquired | 1 | ||||
6/13/2018 | Other Venture Capital | |||||
4/18/2017 |
Cardinal Health Partners & Customers
10 Partners and customers
Cardinal Health has 10 strategic partners and customers. Cardinal Health recently partnered with Signify Health on March 3, 2023.
Date | Type | Business Partner | Country | News Snippet | Sources |
---|---|---|---|---|---|
3/6/2023 | Partner | United States | Cardinal Health collaborates with Signify Health to offer in-home medication management Cardinal Health announces collaboration with Signify Health to offer in-home clinical and medication management services through its Outcomes business . | 6 | |
1/26/2023 | Licensee | United States | Cardinal Health Teams Up with Palantir to Deliver a Clinically Integrated Supply Chain Solution `` Our partnership with Cardinal Health further shows our commitment to improve patient outcomes across the full healthcare value chain and Palantir Technologies Inc. 's ability to create resilience within the complex challenges of supply chain uncertainty , '' said Palantir Technologies Inc. chief operating officer Shyam Sankar . | 3 | |
1/26/2023 | Licensee | United States | Cardinal Health partners with Palantir for data-driven supply chain support As part of the partnership , Palantir Technologies 's operating system Foundry will integrate Cardinal Health solution to combine artificial intelligence and machine learning with diagnosis and clinical data for pharmaceutical products . | 3 | |
12/20/2022 | Vendor | ||||
12/16/2022 | Vendor |
Date | 3/6/2023 | 1/26/2023 | 1/26/2023 | 12/20/2022 | 12/16/2022 |
---|---|---|---|---|---|
Type | Partner | Licensee | Licensee | Vendor | Vendor |
Business Partner | |||||
Country | United States | United States | United States | ||
News Snippet | Cardinal Health collaborates with Signify Health to offer in-home medication management Cardinal Health announces collaboration with Signify Health to offer in-home clinical and medication management services through its Outcomes business . | Cardinal Health Teams Up with Palantir to Deliver a Clinically Integrated Supply Chain Solution `` Our partnership with Cardinal Health further shows our commitment to improve patient outcomes across the full healthcare value chain and Palantir Technologies Inc. 's ability to create resilience within the complex challenges of supply chain uncertainty , '' said Palantir Technologies Inc. chief operating officer Shyam Sankar . | Cardinal Health partners with Palantir for data-driven supply chain support As part of the partnership , Palantir Technologies 's operating system Foundry will integrate Cardinal Health solution to combine artificial intelligence and machine learning with diagnosis and clinical data for pharmaceutical products . | ||
Sources | 6 | 3 | 3 |
Cardinal Health Service Providers
2 Service Providers
Cardinal Health has 2 service provider relationships
Service Provider | Associated Rounds | Provider Type | Service Type |
---|---|---|---|
Acquired Unit | Investment Bank | Financial Advisor | |
Service Provider | ||
---|---|---|
Associated Rounds | Acquired Unit | |
Provider Type | Investment Bank | |
Service Type | Financial Advisor |
Partnership data by VentureSource
Cardinal Health Team
83 Team Members
Cardinal Health has 83 team members, including current Chief Information Officer, Senior Vice President, Michelle D. Greene.
Name | Work History | Title | Status |
---|---|---|---|
Michelle D. Greene | Chief Information Officer, Senior Vice President | Current | |
Name | Michelle D. Greene | ||||
---|---|---|---|---|---|
Work History | |||||
Title | Chief Information Officer, Senior Vice President | ||||
Status | Current |
Compare Cardinal Health to Competitors
RTI designs and manufactures safety medical devices featuring automated retraction technology, proven to effectively reduce the risk of needlestick injuries.

B. Braun Medical develops, manufactures, and markets medical products and services to the healthcare industry. It is based in Bethlehem, Pennsylvania.
Numedico is the a proprietor, manufacturer and wholesaler of the Swiss designed ClickZip technology, including the ClickZip Needle Retractable Safety Syringe, a high-quality quality manual retractable needle injectable delivery system offering minimal dead space.

Parker Hannifin (NYSE: PH) is a corporation that specializes in diversified industries and aerospace systems. It offers services in motion systems, instrumentation, fluid connectors, engineered materials, and filtration. The company was formerly known as Parker Appliance Company. It was founded in 1917 and is based in Cleveland, Ohio.
Terumo (TYO:4543) manufactures and sells medical products and equipment, including pharmaceuticals, nutritional food supplement, blood bags, disposable medical devices, cardiovascular systems, vascular grafts, peritoneal dialysis, blood glucose monitoring system, medical electronic, and digital termometers.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.